Trial intelligence / Profile preview

Nesiritide in Decompensated Heart Failure and Renal Dysfunction

NCT00119691Phase 2Completed

Sponsor
Brigham and Women's Hospital
Start
Apr 2003
Primary completion
Nov 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in heart failure (HF), sponsored by Brigham and Women's Hospital. Started Apr 2003; status: completed.

02

Drugs

nesiritide
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00119691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00119691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call